Hypothalamic gonadotropin-releasing hormone (GnRH) neurons play an important role in promoting secretion of pituitary luteinizing hormone (LH) and ovulation by releasing GnRH peptide. The release of GnRH peptide is generally assumed to be mainly modulated according to the firing activity of GnRH neurons. However, the relationship between the firing activity and the release of GnRH peptide has been elusive. We analyzed the relationship using two lines of transgenic medaka (gnrh1:enhanced green fluorescent protein and lhb:inverse-pericam) for the combined electrophysiological and Ca 2+ imaging analyses. We show that a high-frequency firing activity induced by an excitatory neurotransmitter, glutamate, strongly increases [Ca 2+ ] i in the cell bodies of GnRH1 neurons, which should lead to stimulation of GnRH release. We examined whether this highfrequency firing actually leads to the release of endogenous GnRH1 peptide from the nerve terminals projecting to the pituitary LH cells using a whole brain-pituitary preparation of a fish generated by crossing the two types of transgenic fish. Ca 2+ imaging analyses showed that local glutamate activation of GnRH1 cell bodies, but not their nerve terminals in the pituitary, induced a substantial Ca 2+ response in LH cells that was abolished in the presence of a GnRH receptor antagonist, Analog M. These results suggest that such an evoked high-frequency firing activity of GnRH1 cell body stimulates the release of endogenous GnRH1 peptide from the axon terminals to the pituitary LH cells. Thus, the findings of the present study have clearly demonstrated the relationship between the firing activity of hypothalamic GnRH neurons and the release of GnRH peptide. (Endocrinology 158: 2603(Endocrinology 158: -2617(Endocrinology 158: , 2017 H ypothalamic gonadotropin-releasing hormone (GnRH) neurons, located in the hypothalamus and preoptic area (POA), are conserved throughout vertebrates and form the final common pathway for the regulation of reproduction. The hypothalamic GnRH neurons release the GnRH peptide and stimulate the secretion of luteinizing hormone (LH) from the pituitary, which induces ovulation (1). As the feature of the hypothalamic GnRH neurons, the hypothalamic GnRH neurons in rodents (2-5) and teleosts (6, 7) have been reported to show spontaneous firing activities, which occur independently of external inputs. Recent studies of mice have demonstrated that the spontaneous firing rate of the hypothalamic GnRH neurons in proestrus, when a surge release of GnRH peptide is generated and induces a preovulatory LH surge, is significantly higher than that in other stages of the estrus cycle, diestrus or metestrus (8, 9). In medaka, the hypothalamic GnRH (GnRH1) neurons show time-of-day-dependent changes in their spontaneous firing activities, which has been suggested to be related to the daily ovulatory cycle (6). Thus, the hypothalamic GnRH neurons might modulate their release of GnRH peptide according to the spontaneous firing activities, contributing to a proper regulation of ovulation through stimulating LH secretion.
H ypothalamic gonadotropin-releasing hormone (GnRH) neurons, located in the hypothalamus and preoptic area (POA), are conserved throughout vertebrates and form the final common pathway for the regulation of reproduction. The hypothalamic GnRH neurons release the GnRH peptide and stimulate the secretion of luteinizing hormone (LH) from the pituitary, which induces ovulation (1) . As the feature of the hypothalamic GnRH neurons, the hypothalamic GnRH neurons in rodents (2) (3) (4) (5) and teleosts (6, 7) have been reported to show spontaneous firing activities, which occur independently of external inputs. Recent studies of mice have demonstrated that the spontaneous firing rate of the hypothalamic GnRH neurons in proestrus, when a surge release of GnRH peptide is generated and induces a preovulatory LH surge, is significantly higher than that in other stages of the estrus cycle, diestrus or metestrus (8, 9) . In medaka, the hypothalamic GnRH (GnRH1) neurons show time-of-day-dependent changes in their spontaneous firing activities, which has been suggested to be related to the daily ovulatory cycle (6) . Thus, the hypothalamic GnRH neurons might modulate their release of GnRH peptide according to the spontaneous firing activities, contributing to a proper regulation of ovulation through stimulating LH secretion.
However, unlike the regulation of the classic neurotransmitter release, which is known to be induced by each action potential, the relationship between the firing activity and the release of neuropeptide, including GnRH, is complicated and has not been analyzed in detail. For example, previous studies have reported that highfrequency firing activities promote the release of neuropeptides in some peptidergic neurons, including mice GnRH neurons (10) (11) (12) (13) (14) (15) . However, it has also been reported that the release of neuropeptide occurs even during the application of a voltage-dependent Na + channel blocker, tetrodotoxin, which inhibits action potentials (16) (17) (18) . Classic studies of mammals suggested that the pulsatile multiunit activity (volley) in the medial hypothalamus induces a pulsatile release of LH through pulsatile GnRH peptide release (19) . Recent studies of mouse hypothalamic GnRH neurons showed that the evoked high-frequency firing induces Ca 2+ elevation and GnRH peptide release in nerve terminals (15, 20) . These results suggest the importance of the firing activity of mammalian GnRH neurons in GnRH peptide release. However, it has also been reported that a neuropeptidedependent modulation of the presynaptic GnRH nerve terminals also significantly increases [Ca 2+ ] i and evokes GnRH peptide release independently of action potentials (18, 20) . Thus, the complex manner of regulation of mouse GnRH peptide release has recently been addressed using physiological methods. In contrast, the relationship between hypothalamic GnRH peptide release and the firing activity of GnRH neurons in nonmammalian species has not yet been studied physiologically. In the present study, we addressed a general question of whether the modulation of firing activity of hypothalamic GnRH neurons of vertebrates plays an essential role in the control of GnRH peptide release, which is important for LH release and ovulation.
We focused on the hypothalamic GnRH (GnRH1) neurons in medaka. The GnRH1 neurons in medaka show unique characteristics that provide various advantages for analyzing the relationship between the firing activity and modulation of LH secretion through GnRH peptide release. First, hypothalamic GnRH neurons in teleosts, including medaka, project their axons directly and robustly to the pituitary (21) (22) (23) (24) . This serves as morphological evidence to suggest that the hypothalamic GnRH neurons directly modulate the endocrine systems in the pituitary. Second, GnRH1 has been clearly shown to be an essential and robust regulator of LH release and subsequent ovulation in medaka. The gnrh1 knockout medaka showed no ovulation because of the lack of LH release, and the phenotype was rescued by exogenous administration of an LH agonist in female medaka (25) . Moreover, a physiological study using transgenic medaka, whose LH cells express a florescent Ca 2+ indicator, (26) . Finally, the brain of the medaka is small and transparent, enabling analyses using the whole brain-pituitary preparation. By taking advantage of this whole brainpituitary preparation, the physiological analyses can be performed, while keeping all GnRH1 neuronal projections from the cell bodies to the pituitary intact. Because of these advantages, medaka GnRH1 neurons are considered to be one of the most powerful models for examining whether the firing activity in the cell bodies of hypothalamic GnRH neuron contributes to LH secretion through the release of GnRH peptide.
Therefore, the present study analyzed the relationship between the firing activities of hypothalamic GnRH1 neurons and the release of GnRH1 peptide to the pituitary LH cells using the whole-brain pituitary preparation. The release of endogenous GnRH1 peptide was estimated by analyzing the GnRH1-induced Ca 2+ response in LH cells using lhb:IP transgenic medaka (26) . This is a unique experimental system using the characteristics of hypothalamic GnRH neurons in a teleost, which directly project to the pituitary, combined with the transgenic technique. Using Ca 2+ imaging and patch clamp technique, we analyzed the relationship between the firing activity of GnRH1 neuron and the release of GnRH1 peptide to the LH cells from their nerve terminals.
Materials and Methods

Animals
Sexually mature female gnrh1:enhanced green fluorescent protein (EGFP) transgenic medaka were used for the electrophysiological analysis and Ca 2+ imaging in GnRH1 neurons (6, 21) . For Ca 2+ imaging of LH cells during perfusion and application of various substances, sexually mature female lhb:IP (a fluorescent Ca 2+ indicator) transgenic medaka (26) were used. For Ca 2+ imaging of LH cells during puffer application of glutamate, we used gnrh1:EGFP 3 lhb:IP transgenic medaka, which were generated by crossing gnrh1:EGFP transgenic medaka and lhb:IP transgenic medaka. All the fish were maintained in pairs (sexually mature male and female medaka) under the long-day photoperiod (14 hours light and 10 hours dark; light on at 8:00 AM and light off at 10:00 PM) at a water temperature of 27°C. Sexually mature female medaka were used after checking that they continuously spawned. All the fish were maintained and used in accordance with the Guidelines for Proper Conduct of Animal Experiments (Science Council of Japan). The Animal Care and Use Committee of the University of Tokyo approved the protocol (permission no. 15-3).
Electrophysiology
We used sexually mature female gnrh1:EGFP transgenic medaka. Transgenic medaka were anesthetized by immersion in 0.02% tricaine methanesulfonate (MS-222; Sigma-Aldrich, St. Louis, MO) and decapitated. The whole brain was carefully dissected out, and the optic nerve and meningeal membrane in POA were removed. The spontaneous firing activity of GnRH1 neuron was recorded in accordance with a previous report (27) . The whole brain in vitro preparation was placed in a chamber filled with artificial cerebrospinal fluid (ACSF) containing 134 mM NaCl, 2.9 mM KCl, 2.1 mM CaCl 2 , 1.2 mM MgCl 2 , 4.5 mM glucose, and 10 mM HEPES (with the pH finally adjusted to~7.4 with NaOH and osmolality adjusted to~295 to 300 mOsm/L with sucrose). On-cell loose-patch recordings were performed with an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA), digitized at 10 kHz, and stored using Digidata 1322A and pCLAMP, version 9.2, software (Molecular Devices). The recording pipettes were made from borosilicate glass capillaries (GD-1.5; Narishige, Tokyo, Japan) using a puller (P-97; Sutter Instruments, Novato, CA). The patch pipettes filled with ACSF had a resistance of~8 to 15 MV. Spontaneous action currents were recorded from GnRH1 neurons using a loose seal (~40 to 80 MV seal resistance) voltage clamp mode (holding potential, 0 mV).
To analyze the effect of the perfusion of glutamate (50, 100, and 500 mM and 1 mM) on their spontaneous firing activity, glutamate was perfused for 2 minutes after a 10-minute baseline recording (perfusion of ACSF). After washout for .5 minutes, glutamate of different concentrations was applied for 2 minutes. The instantaneous frequency of the "control" recording 5 to 7 minutes after the start of the baseline recording was calculated using Clampfit, version 10.2, software (Molecular Devices). The instantaneous frequency of "glutamate" was also calculated from the recording during 2 minutes of glutamate perfusion.
For local application to the cell body of GnRH1 neurons, puffer application was performed with an electric microinjector (IM-31; Narishige). Using the microelectrode puller, puffer pipettes were made from borosilicate glass capillaries of 1.0 mm outer diameter (GD-1.0; Narishige). The puffer pipette filled with ACSF or 1 mM glutamate was set at~5 to 10 mm apart from the cell body of GnRH1:EGFP neurons. During perfusion of ACSF, ACSF or glutamate was applied locally twice (10 and 13 minutes after the start of the recording) by puffer application (400 ms, 70 kPa). The instantaneous frequency was calculated from the 10-second recording after puffer application and averaged in two puffer applications for each groups.
Ca
2+ imaging of GnRH1 neurons
The whole brain of female gnrh1:EGFP transgenic medaka was prepared as described in the previous section. After removal of the optic nerve and meningeal membrane, we confirmed that EGFP-positive cells were exposed. If the EGFP-positive cells were covered by other cells or the meningeal membrane, they were removed using a glass cleaning pipette. Next, the whole brain was kept in a handmade recording chamber filled with ACSF for 30 minutes at room temperature. Next, we prepared a 200-mL Fura 2-AM solution [10 mM Fura 2-AM (Dojindo, Kumamoto, Japan) and 0.04% Cremophor EL (Fluka; SigmaAldrich) in ACSF]. The whole brain was incubated in the Fura 2-AM solution for 60 minutes on a rocking platform at 30°C at 30 rpm in a hybridization incubator (HB80; TAITEC Corp., Saitama, Japan). Next, the whole brain preparation was placed in a recording chamber and perfused with ACSF for 30 minutes. Ca 2+ imaging was performed, as previously described (26) . In brief, the GnRH1 neurons were identified by their EGFP fluorescence (at 480 nm), and the fluorescence of Fura 2-AM was detected by at 340 and 380 nm excitation using an EMCCD The peak ratio (F340/F380) for the "control" was calculated as [maximum value of fluorescence ratio (F340/F380) 2 to 4 minutes after the start of recording minus the fluorescence ratio (F340/F380) 0.5 minute after the start of the recording]. The peak ratio (F340/F380) for "glutamate" was calculated as [maximum value of fluorescence ratio (F340/F380) during 2 minutes of perfusion of glutamate minus the fluorescence ratio (F340/F380) 1.5 minutes before the perfusion of glutamate]. For the groups in which the peak ratio (F340/F380) was significantly greater than that for the control, the half maximum width was calculated as the time between the first and last frame that exceeded the half the peak value [fluorescence ratio (F340/ F380) 1.5 minutes before the perfusion plus the peak ratio (F340/F380) divided by 2].
For the puffer application experiments, the ratio of fluorescence intensity (340/380 nm) for the target GnRH1:EGFP neuron that was placed close to the puffer pipette (made by glass capillaries; GD-1.0) and for the off-target GnRH1:EGFP neuron were calculated [fluorescence ratio (F340/F380)]. Puffer application was performed as described previously. The puffer application of ACSF or 1 mM glutamate (400 ms, 70 kPa) was performed 5 and 8 minutes after the start of the baseline recording under perfusion of ACSF. The peak ratio (F340/F380) was calculated as [maximum value of fluorescence ratio (F340/ F380) 1 minute after puffer application (ACSF or glutamate) minus fluorescence ratio (F340/F380) 0.5 minute before puffer application] averaged for two puffer applications. The relative peak ratio of off-target GnRH1 neurons was defined as [the peak ratio (F340/F380) of the off-target GnRH1 neuron divided by the peak ratio (F340/F380) of the target GnRH1 neuron multiplied by 100].
All image data were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD).
Ca
2+ imaging in LHb:IP cells Ca 2+ imaging in LH cells was performed using sexually mature female lhb:IP transgenic medaka for perfusion experiments or using gnrh1:EGFP 3 lhb:IP transgenic medaka for puffer application. IP is known as a fluorescent Ca 2+ indicator whose intensity of fluorescence is high in low concentrations of Ca 2+ and is low in high concentrations of Ca 2+ (28) . Ca 2+ imaging using the LHb:IP cells was performed as described in the previous report (26) , with minor modifications. In brief, the transgenic medaka were anesthetized by immersion in 0.02% MS-222 and decapitated. ] i of LH cells, glutamate was perfused for 2 minutes after the 5-minute baseline recording. After washout by ACSF (for $5 minutes), glutamate at different concentrations was also perfused for 2 minutes. The peak DF/F0 for "control" was calculated as [(maximum value of DF/F0 2 to 4 minutes after the start of recording) minus (value of DF/F0 0.5 minute after the start of recording)]. The peak DF/F0 for "glutamate" was calculated as [(maximum value of DF/F0 during 2 minutes of perfusion of glutamate) minus (value of DF/F0 1.5 minutes before the perfusion of glutamate)].
For analysis of the relationship between the effect of perfusion of glutamate and GnRH1 peptide release, we first perfused 1 mM glutamate for 2 minutes after the 5-minute baseline recording (first glutamate). After the 5-minute washout, 1 mM
, which was reported as a GnRH receptor antagonist (26) , was perfused for 2 minutes. Next, 1 mM glutamate was perfused in the presence of 1 mM Analog M for 2 minutes (glutamate plus Analog M). Next, 1 mM glutamate was perfused for 2 minutes after a 10-minute washout (second glutamate) and a 20-minute washout (third glutamate). The peak DF/F0 for each group was calculated as [(maximum value of DF/F0 during 2 minutes of perfusion) minus (value of DF/F0 1.5 minutes before the perfusion)]. The normalized peak DF/F0 was defined as [peak DF/F0 (each group) divided by peak DF/F0 (first glutamate) multiplied by 100].
For the puffer application experiments, the puffer pipette (filled with ACSF or 1 mM glutamate) was set near the GnRH1: EGFP cell bodies in POA or their nerve terminals in the pituitary by checking their GFP fluorescence. During ACSF perfusion, a puff of ACSF or 1 mM glutamate was applied (400 ms, 70 kPa) 5 and 8 minutes after the start of the recording. The peak DF/F0 was calculated as [(maximum value of DF/F0 within 1 minute after the puffer application) minus (value of DF/F0 0.5 minute before puffer application)], which was averaged for two puffer applications.
To analyze the relationship between the puffer application of glutamate to the GnRH1 cell body and GnRH receptor activation in LH cells, a puff of 1 mM glutamate (400 ms, 70 kPa) was first applied 5 and 8 minutes after the start of the baseline recording (first glutamate) during perfusion of ACSF. Next, 1 mM Analog M in ACSF was perfused from 11 to 17 minutes after the start of recording. In the presence of Analog M, another puff of 1 mM glutamate (400 ms, 70 kPa) was applied 13 and 16 minutes after the start of recording (glutamate plus Analog M). Puffer application of 1 mM glutamate was also performed 10 and 13 minutes (second glutamate), 20 and 23 minutes (third glutamate), and 30 and 33 minutes (fourth glutamate) after washout of ACSF. The peak DF/F0 for each group was calculated as described, and the normalized peak DF/F0 for each group was defined as [peak DF/F0 (each group) divided by peak DF/F0 (first glutamate) multiplied by 100].
All the image analyses were performed using ImageJ software (National Institutes of Health).
Drugs
Glutamate (L-glutamic acid monosodium salt hydrate) was purchased from Sigma-Aldrich. GnRH receptor antagonist, 2 ) was synthesized by GL Biochem (Shanghai, China). The stock solutions of glutamate (100 mM) and Analog M (1 mM) were dissolved in distilled deionized water.
Statistical analysis
All the data are presented as the mean 6 standard error of the mean. Statistical analyses were performed using Kyplot5 software (Kyence, Tokyo, Japan). We used a two-tailed paired t test for statistical analyses between paired two groups and Welch t test for those between unpaired two groups. Statistical analyses between control and multiple groups were performed using the Dunnett test. For the comparison between all groups, we used the Tukey test. P , 0.05 was considered to indicate a statistically significant difference.
Results
Glutamate induces high-frequency firing activity of GnRH1 neurons
To examine whether high-frequency firing in GnRH1 neurons induces the release of GnRH1 peptide, we used glutamate, which is well-known as an excitatory neurotransmitter in vertebrates, to induce their highfrequency firing activity. First, we analyzed the effect of glutamate on the firing activity of GnRH1 neuron. Perfusion of glutamate strongly activated the firing activity of GnRH1 neuron [ Fig. 1(a) ]. Perfusion of glutamate ($100 mM) significantly increased the mean instantaneous frequency [ Fig. 1(b) ; control, 2.1 6 0.3 Hz (n = 12 neurons from six fish), 50 mM glutamate, 3.9 6 0.7 Hz (n = 9 neurons from six fish); 100 mM glutamate, 6.1 6 0.7 Hz (n = 8 neurons from six fish); 500 mM glutamate, 8.4 6 0.9 Hz (n = 7 neurons from six fish); 1 mM glutamate, 7.7 6 1.4 Hz (n = 7 neurons from five fish); P , 0.01 for control vs 100 mM glutamate, P , 0.001 for control vs 500 mM or 1 mM glutamate, Dunnett test] and the median instantaneous frequency [ Fig. 1(c) ; control, 1.3 6 0.3 Hz (n = 12 neurons from six fish); 50 mM glutamate, 3.2 6 0.7 Hz (n = 9 neurons from six fish); 100 mM glutamate, 5.1 6 0.7 Hz (n = 8 neurons from six fish); 500 mM glutamate, 6.3 6 0.8 Hz (n = 7 neurons from six fish); 1 mM glutamate, 5.4 6 0.7 Hz (n = 7 neurons from five fish); P , 0.001 for control vs 100 mM and 500 mM or 1 mM glutamate; Dunnett test].
Puffer application of 1 mM glutamate to the recorded GnRH1 neuron also induced a high-frequency firing activity similar to the perfusion of glutamate; however, puffer application of ACSF did not [ Fig. 2(a), and 2(b) ]. The mean instantaneous frequency during puffer application of glutamate was significantly greater than that during the puffer application of ACSF [ Fig. 2(c) ; ACSF, 1.1 6 0.4 Hz (n = 7 neurons from three fish); 1 mM glutamate, 7.3 6 1.5 Hz (n = 6 neurons from three fish); P , 0.01, Welch t test], similar to the result of median instantaneous frequency [ Fig. 2(d) ; ACSF, 1.0 6 0.3 Hz (n = 7 neurons from three fish); 1 mM glutamate, 5.8 6 1.0 Hz (n = 6 neurons from three fish); P , 0.01, Welch t test].
These results suggest that bath and puffer applications of glutamate induce high-frequency firing of the GnRH1 neurons.
Glutamate strongly increases [Ca 2+ ] i in GnRH1 neurons
The exocytosis of large dense-core vesicles containing neuropeptides is mediated by the increase in [Ca 2+ ] i (29 Fig. 3(a) ]. Figure 3(b) shows the peak ratio (F340/F380) and the perfusion of $50 mM concentrations of glutamate induced substantial increases in [Ca 2+ ] i [ Fig. 3(b) ; control, 0.017 6 0.005; 10 mM glutamate, 0.055 6 0.021; 50 mM glutamate, 0.17 6 0.03; 100 mM glutamate, 0.21 6 0.04; 500 mM glutamate, 0.25 6 0.04; 1 mM glutamate, 0.22 6 0.05 (n = 6 from six fish); P , 0.05 for control vs 50 mM glutamate; P , 0.01 for control vs 100 mM glutamate; P , 0.001 for control vs 500 mM or 1 mM glutamate, Dunnett test]. In addition, the half maximum width of the Ca 2+ response showed a dose-dependent increase [ Fig. 3(c) ; 50 mM glutamate, 2.5 6 0.2 minutes; 100 mM glutamate, 3.3 6 0.4 minutes; 500 mM glutamate, 6.2 6 1.1 minutes; 1 mM glutamate, 7.4 6 1.2 minutes (n = 6 from six fish); Fig. 4(c) ; ACSF, 0.0061 6 0.0016; 1 mM glutamate, 0.13 6 0.02 (n = 9 neurons from three fish); P , 0.001, two-tailed paired t test]. Off-target GnRH1 neurons were also loaded with Fura 2-AM (,100~150 mm), surrounding the target GnRH1 neuron [ Fig. 4(d) ]. The puffer application of glutamate with the present parameters (400 ms, 70 kPa) also activated these off-target GnRH1 neurons, similar to the target GnRH1 neurons [ Fig. 4(e) ]. Most of the off-target GnRH1:EGFP neurons (78%) showed high Ca 2+ response ratios (.50% of the Ca 2+ response in the These results show that [Ca 2+ ] i in multiple GnRH1 neurons is significantly increased, not only by the perfusion, but also by the puffer application of glutamate.
Perfusion of glutamate induces the release of GnRH1 peptide to act on the LHb:IP cells in the pituitary
Previous studies of medaka reported that GnRH1 neurons mainly project to the LH cells in the pituitary (21) Fig. 5(a) ]. The peak Ca 2+ response (DF/F0) during the perfusion of 500 mM or 1 mM glutamate was significantly greater than that during control [ Fig. 5(b) ; control, 0.011 6 0.002 (n = 8 from eight fish); 100 mM glutamate, 0.018 6 0.006 (n = 7 from seven fish); 500 mM glutamate, 0.048 6 0.015 (n = 8 from eight fish); 1 mM glutamate, 0.073 6 0.010 (n = 8 from eight fish); P , 0.05 for control vs 500 mM glutamate; P , 0.001 for control vs 1 mM glutamate, Dunnett test].
We also examined whether this glutamate-induced Ca 2+ response in the LHb:IP cells is triggered by the release of GnRH1 peptide and activation of GnRH receptors using a GnRH receptor antagonist, Analog M. The peak ratio (F340/F380) in the following six groups: control, 10 mM, 50 mM, 100 mM, 500 mM, and 1 mM glutamate (n = 6). (c) The time width at half maximum in the following four groups: 50 mM, 100 mM, 500 mM, and 1 mM glutamate (n = 6). Error bars represent standard error of the mean. (b) Dunnett test; *P , 0.05; **P , 0.01; ***P , 0.001. (c) Bars with different lowercase letters denote statistically significant differences (P , 0.05, Tukey test). Ca 2+ response to the glutamate puffer application to the GnRH1 cell body was significantly greater than that to the ACSF application to the cell body and glutamate application to the pituitary [ Fig. 6(d) ; ACSF to GnRH1 cell body, 0.0063 6 0.0027; 1 mM glutamate to GnRH1 cell body, 0.037 6 0.006; 1 mM glutamate to pituitary, 0.0064 6 0.0021 (n = 5 from five fish); P , 0.001 for 1 mM glutamate to GnRH1 cell body vs ACSF to GnRH1 cell body or 1 mM glutamate to pituitary, Tukey test]. Furthermore, the Ca 2+ response in LH cells evoked by puffer application of glutamate to the GnRH1 cell body was abolished during the perfusion of Analog M and recovered by washout [ Fig. 6 (e) and 6(f), normalized peak DF/F0; glutamate plus Analog M, 26% 6 7%; second glutamate, 43% 6 19%; third glutamate, 64% 6 18%; fourth glutamate, 103% 6 21% (n = 5 from five fish); P , 0.05 for first glutamate or fourth glutamate vs glutamate plus Analog M, Tukey test]. These results suggest that glutamate activation in the cell body of GnRH1 neurons stimulates endogenous GnRH1 peptide release to the pituitary LH cells.
Discussion
In the present study, we sought to clarify the relationship between the firing activities of hypothalamic GnRH1 neurons and the release of GnRH1 peptide by focusing on the medaka hypothalamic GnRH1 neurons and their target, pituitary LH cells. The physiological analyses showed that glutamate-induced high-frequency firing activities (.6 ; 8 Hz) of GnRH1 neurons can induce an increase in [Ca 2+ ] i in the cell bodies, which should be able to trigger GnRH1 peptide release. Furthermore, Ca 2+ imaging demonstrated that perfusion and puffer application of glutamate to the cell body of GnRH1 neurons increases [Ca 2+ ] i in LHb:IP cells, which is mediated by release of GnRH1 peptide. Because the vast majority of central excitatory synapses use glutamate, these results suggest that glutamatergic excitatory synaptic inputs strong enough to induce high-frequency firing in the cell bodies of GnRH1 neurons can trigger release of endogenous GnRH1 peptide from the nerve terminals to activate pituitary LH cells, which, in turn, release LH.
Regulation of firing frequency in GnRH1 neuron using glutamate
The release of neuropeptide, including GnRH peptide, has generally been considered to require high-frequency firing activity (10) (11) (12) , although the relationship between the firing activity and the peptide release has not yet been detailed. Thus, we examined whether the increased firing frequency of the GnRH1 neurons actually triggers peptide release, by taking advantage of the medaka GnRH1 neurons mentioned above. In the present study, a conventional excitatory neurotransmitter glutamate was used for upregulating the firing frequency in the GnRH1 neurons. Electrophysiological analyses showed that the perfusion and puffer applications of glutamate induce high-frequency firing activity (.6 ; 8 Hz) of GnRH1 neurons (Figs. 1 and 2) . As the other neurotransmitter candidates for the GnRH1 neurons, g-aminobutyric acid (GABA) and kisspeptin have been reported to directly activate the firing activity of hypothalamic GnRH neurons in mammals (30) (31) (32) . Although our preliminary analysis demonstrated that GABA also acts as an excitatory transmitter for the GnRH1 neurons in medaka, the excitatory effect was much smaller than glutamate and required extremely high concentrations (data not shown). Although a general consensus has been reached that kisspeptin directly stimulates hypothalamic GnRH neurons in mammals, a previous study by Kanda et al. (33) showed that GnRH1 neurons do not express the kisspeptin receptor in medaka. Therefore, glutamate is the most probable candidate neurotransmitter for the upregulation of firing frequency in medaka GnRH1 neurons in vivo; thus, we used it for a series of experiments in the present study.
Perfusion of glutamate actually triggers release of endogenous GnRH1 peptide
In the present study, we analyzed the release of GnRH1 peptide from the nerve terminals in the pituitary by measuring intrinsic GnRH1-induced Ca ] i response in LH cells equivalent to the perfusion of medaka GnRH peptide at high concentrations (data not shown). Therefore, the highfrequency firing activities of GnRH1 neurons might induce release of a sufficient amount of endogenous GnRH1 peptide for LH surge, which is considered to induce ovulation.
The perfusion of a high concentration (500 mM, 1 mM) of glutamate significantly increased [Ca 2+ ] i in LHb:IP cells, and the firing activity of POA GnRH1 neurons was significantly activated by a lower concentration (100 mM) of glutamate ( Figs. 1 and 5 ). Because we removed the meningeal membrane and other neurons that covered POA GnRH1:EGFP neurons during recording of the firing activity, glutamate fully acted on the recorded GnRH1 neurons. Although the meningeal (13, 18) . In the present study, we observed a substantial increase of [Ca 2+ ] i in the cell bodies of GnRH1 neurons by the perfusion of glutamate (Fig. 3) . Given that [Ca 2+ ] i
showed an increase in the LH cells by the stimulation of GnRH1 neurons at the cell bodies in POA, it is strongly suggested that the [Ca 2+ ] i increase also occurred in their nerve terminals in the pituitary, which was technically difficult to demonstrate directly in the present study. The peak amplitude of the Ca 2+ response in GnRH1 neurons reached a plateau at 50 to 100 mM glutamate [ Fig. 3(b) ]. In contrast, the half maximum width of the [Ca 2+ ] i signals during the perfusion of 1 mM glutamate was significantly longer than that at 50 to 100 mM [ Fig. 3(c) High-frequency firing in multiple GnRH cell bodies by puffer application of glutamate promotes GnRH1 peptide release
Although the present perfusion experiments suggested that glutamate-induced high-frequency firing in GnRH1 cell bodies promotes the release of GnRH1 peptide, a possibility could not be ruled out that glutamate acted, not only on the cell bodies of the GnRH1 neurons, but also on their nerve terminals. It has been reported that glutamate receptors are expressed in the nerve terminals of hypothalamic GnRH neurons in rats, suggesting that glutamate can modulate the release of GnRH peptides in their nerve terminals (34, 35) . Furthermore, the perfusion of glutamate should also have activated non-GnRH1 neurons in the surface of the whole brain. Therefore, it is possible that glutamate activated the nerve terminal of GnRH1 neurons and these non-GnRH1 neurons and affected the release of GnRH1 peptide and/or Ca 2+ response in LH cells. Therefore, we analyzed the direct relationship between the firing activity in the cell body of GnRH1 neurons and the release of GmRH1 peptide by puffer application of glutamate. (Fig. 6 ). These results clearly
show that the evoked high-frequency firing in the GnRH1 cell body induces the release of GnRH1 peptide to the pituitary LH cells. The present study also demonstrated that highfrequency firing of the GnRH1 cell body caused by local application of glutamate is sufficient for GnRH1 peptide release from their nerve terminals but that local application of glutamate to the nerve terminals is not. In contrast, it has been reported that kisspeptin directly induces a Ca 2+ increase in the nerve terminal of GnRH neurons and evokes the release of GnRH peptide in mice, independently of the firing activity (18, 20) . Therefore, direct modulation of GnRH1 nerve terminals that sufficiently increases [Ca 2+ ] i might also be able to induce GnRH1 peptide release in medaka. To date, strong modulators of GnRH1 nerve terminals in medaka have not been found. Puffer application of glutamate to the GnRH1 nerve terminals did not induce GnRH1 peptide release in the present study (Fig. 6) . Also, kisspeptin, a strong activator for the GnRH neuron in mammals, has been reported in medaka to not stimulate GnRH1 neurons directly (33) . Therefore, it could be interesting in the future to examine whether direct modulation of nerve terminals of the hypothalamic GnRH neurons exist throughout vertebrates.
In the present study, puffer application of glutamate was performed at a high concentration (1 mM) for a relatively long time (400 ms) to reliably induce the highfrequency activity of the target GnRH1 neuron. We found that the present puffer application of glutamate also significantly increased [Ca 2+ ] i in the off-target GnRH1 neurons (;10 cells) within approximately 100 mm from the target GnRH1 neurons simultaneously, which might have resulted from diffusion of glutamate (Fig. 4) . The classic works in the rhesus monkey reported that pulsatile increases in the multiunit electrical activity in the mediobasal hypothalamus, which is suggested to be accompanied by the synchronized firing of hypothalamic GnRH neurons, induces LH pulses (36, 37) . A recent study in mice showed that high-frequency optogenetic activation of multiple GnRH neurons promotes the pulselike release of LH (15) . It has been also reported that the synchronization of [Ca 2+ ] i , which is strongly related to firing activity, contributes to the secretion of GnRH peptide in monkey and mice GnRH neurons (38, 39) . Based on the present analyses and these previous reports, the synchronization of high-frequency firing of multiple GnRH neurons might be essential for the sufficient release of GnRH peptide to induce LH secretion and subsequent ovulation. The dendritic bundling interactions and shared synapses between GnRH neurons, which are suggested to contribute to the synchronization, have been reported in mice (40) . In the cichlid fish, hypothalamic (POA) GnRH1 neurons have been reported to be connected to each other by electrical synapses (41) . Future analysis of the neural mechanisms for synchronized firing among hypothalamic GnRH neurons might contribute to the understanding of the mechanisms for sufficient release of LH before ovulation.
Role of spontaneous firing activity of GnRH1 neurons in the release of GnRH1 peptide
The results of the present study strongly suggest that the evoked high-frequency firing activity of GnRH1 neuron induces the endogenous release of GnRH1 peptide from their nerve terminals in the pituitary. In sexually mature female medaka, the mean firing rate of hypothalamic GnRH1 neurons has been reported to be high in the afternoon (6) . Although the mean value of firing rate was not that high (~1.5 spikes/s) even in the afternoon (6), we found that some GnRH1 neurons spontaneously show irregular high-frequency (burst) firing (.6 Hz) for a short period, similar to the evoked bursting by glutamate (data not shown). It has been reported that hypothalamic GnRH neurons in mammals also show spontaneous highfrequency (bursting) activity (2, 42, 43) . Therefore, hypothalamic GnRH neurons in vertebrates might generally possess the neuronal mechanisms for generating the highfrequency firing that induces GnRH peptide release.
It has been suggested that activities of various intrinsic ion channels such as small conductance calcium-activated potassium currents, hyperpolarization-activated currents, and T-type calcium currents contribute to the generation of bursting activities of hypothalamic GnRH neurons in mice (44) (45) (46) (47) . Therefore, it is possible that the control of high-frequency busting activity is also mediated by these intrinsic ion channel activities in medaka. A previous study of rodents reported that the bursting activity of hypothalamic GnRH neuron is independent of the excitatory glutamatergic/GABAergic inputs (48) . In our preliminary experiment, GnRH1 neurons in medaka also showed spontaneous bursting activity in the presence of inhibitors for ionotropic glutamate receptors (data not shown). Further analyses of the modulation mechanism of high-frequency bursting activity in GnRH1 neurons are important for the understanding of the proper regulation of GnRH peptide release.
Conclusions
We have demonstrated that the glutamate-induced highfrequency firing activity of the GnRH1 cell bodies in medaka induces the release of endogenous GnRH1 peptide from the nerve terminal to the pituitary LH cells. The findings from the present analyses clearly suggest the importance of the firing activity, especially highfrequency firing, in GnRH cell body for the release of GnRH peptide from the nerve terminals. However, recent studies of mice reported that GnRH release from the nerve terminals is evoked by kisspeptin, which is known to play an essential role in reproduction in mammals, independently of firing activity (18, 20) . Although our previous study showed that kisspeptin is not directly involved in the regulation of GnRH neurons in medaka (33) , it might be possible that other neural systems directly act on the nerve terminals to modulate GnRH peptide release, independently of the firing activity. The present experimental system, which takes advantage of transgenic medaka, enabled us to record endogenous GnRH peptide release in the whole brain-pituitary preparation, in which GnRH projections from the cell bodies to the nerve terminals in the pituitary were kept intact. Therefore, future studies using this experimental model should be very helpful in revealing the neural mechanisms for the firing activity-dependent and -independent regulations of GnRH peptide release.
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